Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jonathan Javitch
Columbia University Health Sciences, Department: Psychiatry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kures
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Javitch is co-founder of a new startup company called Kures, and holds equity in this non-public company. Columbia has determined that the company’s aims (commercialization of therapies relating to tianeptine analogs) are related to the project being pursued by Dr. Javitch’s trainee ((b)(6)) under this T32 award; that the outcome of this research could affect the company or Dr. Javitch’s significant financial interest in the company; and that the design, conduct, and/or reporting of this research could be affected by this financial interest.
Training in Schizophrenia and Psychotic Disorders: From Animal Models to Patients
The goal of this program is to train postdoctoral (MD, MD/PhD, and PhD) fellows for careers as independent researchers in Schizophrenia. An intensive three-year program is outlined in which fellows will learn how to identify key research questions, formulate hypotheses, and design and execute experiments that effectively test those hypotheses. Fellows will acquire skills necessary to do research including expertise in experimental design and statistical analysis relevant to basic, translational and clinical research programs, understanding the administrative organization of a successful research enterprise, collaboration with other researchers, and how to write grants and obtain funding through federal grants, private foundations and other sources.
Filed on September 20, 2017.
Tell us what you know about Jonathan Javitch's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.